Smart pill bottles may boost adherence to oral breast cancer therapies through daily reminders and tracking, though cost and ...

Genetic and metabolic differences may increase aggressive early breast cancer risk in Latin American women with obesity, ...

Urinary incontinence (UI) and overactive bladder (OAB) are more common adverse health outcomes in patients who have ...

The guidelines promote whole, nutrient-rich foods and reduced added sugars and processed items to improve national health. A healthy diet includes vegetables, fruits, legumes, nuts, whole grains, and ...

The CDC's shared decision-making approach for vaccinations is misunderstood, leading to public confusion and potential undermining of vaccine confidence. Surveys show many Americans incorrectly ...

A meta-analysis of recent clinical trials evaluating β-blockers as treatment for patients with acute myocardial infarction (MI) and preserved left ventricular ejection fraction (LVEF) found this ...

Following the FDA approval of rilzabrutinib (Wayrilz; Sanofi) for immune thrombocytopenia (ITP), a rare autoimmune disorder, David Kuter, MD, DPhil, highlights the most pressing a ...

Managed care organization and providers should conduct early formulary reviews and education to ensure rapid access to dextromethorphan-bupropion upon approval, potentially delaying facility placement ...

Recent trials highlight T-DXd's superior efficacy and manageable toxicity in treating high-risk HER2-positive breast cancer, reshaping treatment strategies.

Managed care organizations should evolve cost models to capture savings from dextromethorphan-bupropion’s safety profile, which avoids costly complications associated with traditional Alzheimer ...

Peter Voorhees, MD, emphasizes the importance of carefully determined early regimens for smoldering myeloma and involving ...

The poster, presented by William Audeh, MD, MS, chief medical officer of Agendia, cited results from the MammaPrint, ...